Abstract
Basal cell carcinosarcoma (BCCS) is a rare malignant biphasic tumor of the skin, composed of epithelial and mesenchymal components, and may be underdiagnosed. We sought to summarize the current understanding of BCCS including its reported history, clinical presentation, diagnosis, and treatment. We also reappraise and present our recommendations of histological interpretation for its diagnosis and treatment. A systematic review of PubMed and EMBASE, from inception of databases to December 1, 2022, identified all reported cases of basal cell carcinosarcoma. A total of 34 reports containing 54 patients with basal cell carcinosarcoma were included. The neoplasm was most commonly associated in areas of sun-exposed skin and primarily affected the elderly. Diagnosis was made on histology specimens using H&E. To address underdiagnosis, additional immunohistochemical markers have been proposed due to unreliable phenotypic appearance in this poorly differentiated neoplasm. Treatment consists of excision of the tumor, typically with Mohs surgery, and is curative in most cases. There are limited treatment options for metastatic disease. There were limitations to this study as various immunohistochemical stains used on suspected BCCS without providing an explanation as to why certain markers were included and others were excluded. Continued efforts in characterizing this complex neoplasm are critical in establishing reliable and accurate diagnostic tests and accompanying treatment options, especially in cases of metastatic disease.
Similar content being viewed by others
Data availability
Data available within the article.
Abbreviations
- BCCS:
-
Basal cell carcinosarcoma
- BCC:
-
Basal cell carcinoma
- bcl-2:
-
B-Cell lymphoma 2
- EMA:
-
Epithelial membrane antigen
- PRKACG:
-
Protein kinase cAMP-activated catalytic subunit gamma
References
Mijušković Ž, Brašanac D, Rajović M, Sekulović LK (2020) Overgrowth of undifferentiated pleomorphic sarcoma during vismodegib treatment of locally advanced basal cell carcinosarcoma. JCO Oncol Pract 16(12):839–841. https://doi.org/10.1200/OP.20.00405
Song EY, Wallace SJ, Sheikh H, Wojcik R Jr, Nayak C (2020) Cutaneous carcinosarcoma: a small case series and review of the literature of a rare skin tumor. Cureus. https://doi.org/10.7759/CUREUS.9569
Suzuki H, Hashimoto A, Saito R, Izumi M, Aiba S (2018) A case of primary cutaneous basal cell carcinosarcoma. Case Rep Dermatol 10(2):208–215. https://doi.org/10.1159/000492525
Davis K, Whale K, Tran S, Hamilton S, Kandamany N (2020) A rare case of cutaneous basal cell carcinosarcoma in an immunosuppressed patient. Pathology 52(2):267–268. https://doi.org/10.1016/J.PATHOL.2019.10.011
Xu C, Ibbetson J, Yeoh TM, Harries RHC (2016) Aggressive growth of an incompletely excised primary cutaneous basal cell carcinosarcoma on the scalp: a case report. ANZ J Surg 86(12):1065–1066. https://doi.org/10.1111/ANS.13620
Harvey NT et al (2014) Basal cell carcinosarcoma: a report of 4 cases and review of the literature. Am J Dermatopathol 36(6):483–489. https://doi.org/10.1097/DAD.0000000000000017
Zbacnik AP, Rawal A, Lee B, Werling R, Knapp D, Mesa H (2015) Cutaneous basal cell carcinosarcoma: case report and literature review. J Cutan Pathol 42(11):903–910. https://doi.org/10.1111/CUP.12578
Fernandez C, Forrest P, Sivalingam M, Milman T, Ramesh S, Shi W (2021) Exenteration and adjuvant radiotherapy for primary carcinosarcoma of the anterior orbit: a case report. Ophthalmic Plast Reconstr Surg. https://doi.org/10.1097/IOP.0000000000001911
Sterner JK, Rizk K, Braudis KM, Tuncer T, Smith EH (2021) Metastatic basal cell carcinoma arising from a primary cutaneous carcinosarcoma. Oncology (Williston Park) 35(12):812–815. https://doi.org/10.46883/2021.25920933
Cen Y, Huang Z, Ren J, Zhang J, Gong Y, Xie C (2020) The characteristic of tumor immune microenvironment in pulmonary carcinosarcoma. Immunotherapy 12(5):323–331. https://doi.org/10.2217/IMT-2019-0123
Schuch LF, de Arruda JAA, Silva LVO, Abreu LG, Silva TA, Mesquita RA (2018) Odontogenic carcinosarcoma: a systematic review. Oral Oncol 85:52–59. https://doi.org/10.1016/J.ORALONCOLOGY.2018.08.017
Matsuzaki S, Klar M, Matsuzaki S, Roman LD, Sood AK, Matsuo K (2021) Uterine carcinosarcoma: contemporary clinical summary, molecular updates, and future research opportunity. Gynecol Oncol 160(2):586–601. https://doi.org/10.1016/J.YGYNO.2020.10.043
Kim C, Brown A, Osipov V (2021) Trichoblastic carcinosarcoma in a 34-year-old woman with histopathologic and molecular analysis, including re-demonstration of a CDKN2A p. (R58*) mutation. J Cutan Pathol 48(2):334–339. https://doi.org/10.1111/CUP.13892
Underwood CIM, Mansoori P, Selim AM, Al-Rohil RN (2020) Trichoblastic carcinosarcoma: a case report and literature review. J Cutan Pathol 47(4):409–413. https://doi.org/10.1111/CUP.13614
Gamret AC et al (2019) Carcinosarcoma of the hand. Dermatol Online J. https://doi.org/10.5070/d3256044498
Chung HJ, Wolpowitz D, Scott G, Gilmore E, Bhawan J (2016) Squamous cell carcinoma with osteoclast-like giant cells: a morphologically heterologous group including carcinosarcoma and squamous cell carcinoma with stromal changes. J Cutan Pathol 43(2):148–157. https://doi.org/10.1111/CUP.12607
Kwon DH et al (2021) Cutaneous adnexal carcinosarcoma: immunohistochemical and molecular evidence of epithelial mesenchymal transition. J Cutan Pathol 48(4):526–534. https://doi.org/10.1111/CUP.13782
Dawson EK (1972) Carcino-sarcoma of the skin. J R Coll Surg Edinb 17(4):243–246. https://doi.org/10.1097/00000372-199612000-00012
Quay SC, Harrist TJ, Mihm MC (1981) Carcinosarcoma of the skin. Case report and review. J Cutan Pathol 8(3):241–246. https://doi.org/10.1111/J.1600-0560.1981.TB01004.X
Ríos-Martín JJ, Parra-Martín JA, Gómez-Pascual A, Hevia-Vázquez A, González-Cámpora R (1998) Sarcomatoid carcinoma of the skin: report of a case. J Dermatol 25(5):314–321. https://doi.org/10.1111/J.1346-8138.1998.TB02404.X
Mcmenamin ME, Goh SGN, Poblet E, Gostelow BE, Robson A, Calonje E (2006) Sarcomatoid basal cell carcinoma—predilection for osteosarcomatous differentiation: a series of 11 cases. Am J Surg Pathol 30(10):1299–1308. https://doi.org/10.1097/01.PAS.0000208900.23483.BA
Tran TA, Muller S, Chaudahri PJ, Carlson JA (2005) Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis. J Cutan Pathol 32(1):2–11. https://doi.org/10.1111/J.0303-6987.2005.00260.X
Agostini T, Mori A, Leporatti G, Dini M, Franchi A (2008) Cutaneous carcinosarcoma: report of a case with myofibroblastic sarcomatous component. Dermatol Surg 34(3):418–422. https://doi.org/10.1111/J.1524-4725.2007.34083.X
Namikawa K, Takahashi T, Nakamura Y, Otsuka F (2008) Cutaneous carcinosarcoma comprising basal cell carcinoma and CD34+ fibrosarcoma. J Eur Acad Dermatol Venereol 22(6):757–758. https://doi.org/10.1111/J.1468-3083.2007.02463.X
Bigby SM, Charlton A, Miller MV, Zwi LJ, Oliver GF (2005) Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature. J Cutan Pathol 32(2):141–147. https://doi.org/10.1111/J.0303-6987.2005.00276.X
Suh KY, Lacouture M, Gerami P (2007) p63 in primary cutaneous carcinosarcoma. Am J Dermatopathol 29(4):374–377. https://doi.org/10.1097/DAD.0B013E31812F52BD
Pazzini R, Pereira GA, Macarenco RS (2018) Cutaneous metaplastic carcinoma: report of a case with sebaceous differentiation. Am J Dermatopathol 40(7):E100–E103. https://doi.org/10.1097/DAD.0000000000001070
Bhattacharjee P, Leffell D, McNiff JM (2005) Primary cutaneous carcinosarcoma arising in a patient with nevoid basal cell carcinoma syndrome. J Cutan Pathol 32(9):638–641. https://doi.org/10.1111/J.0303-6987.2005.00384.X
Izaki S et al (1993) Carcinosarcoma of the skin: immunohistochemical and electron microscopic observations. J Cutan Pathol 20(3):272–278. https://doi.org/10.1111/J.1600-0560.1993.TB00655.X
Rouas L, Amrani M, Regragui A, Gamra L, Bellabas MA (2006) Carcinosarcoma of the skin. Ann Dermatol Venereol 133(4):362–365. https://doi.org/10.1016/S0151-9638(06)70916-4
Kwak HB, Park J, Kim HU, Nam KH, Yun SK (2019) Cutaneous carcinosarcoma: a clinicopathologic and immunohistochemical analysis of 11 Korean Cases. J Korean Med Sci. https://doi.org/10.3346/JKMS.2019.34.E5
Gomes A, Teixeira C, Ferraz R, Prudencio C, Gomes P (2017) Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules. https://doi.org/10.3390/molecules22101743
Heathcote JG, Moss P, Walsh NM, Archibald CW (2021) Basal cell carcinosarcoma of the eyelid with osteosarcomatous transformation. Saudi J Ophthalmol 35(3):257. https://doi.org/10.4103/SJOPT.SJOPT_35_21
Carrasquillo OY, Cruzval-O’Reilly E, Sánchez JE, Valentín-Nogueras SM (2021) Differentiation of basal cell carcinoma and trichoepithelioma: an immunohistochemical study. Am J Dermatopathol 43(3):191–197. https://doi.org/10.1097/DAD.0000000000001783
Stanoszek LM, Wang GY, Harms PW (2017) Histologic mimics of basal cell carcinoma. Arch Pathol Lab Med 141(11):1490–1502. https://doi.org/10.5858/ARPA.2017-0222-RA
Memije MEV, Luna EM, De Almeida OP, Taylor AM, González JCC (2014) Immunohistochemistry panel for differential diagnosis of Basal cell carcinoma and trichoblastoma. Int J Trichol 6(2):40–44. https://doi.org/10.4103/0974-7753.138583
Bourgeault E, Alain J, Gagné E (2015) Primary cutaneous carcinosarcoma of the basal cell subtype should be treated as a high-risk basal cell Carcinoma. J Cutan Med Surg 19(4):407–411. https://doi.org/10.1177/1203475415575233
Kloth K et al (2021) Defining the spectrum, treatment and outcome of patients with genetically confirmed gorlin syndrome from the HIT-MED cohort. Front Oncol. https://doi.org/10.3389/FONC.2021.756025
Yang XH et al (2022) Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers. Gene. https://doi.org/10.1016/J.GENE.2021.146157
Rodriguez-Acevedo AJ et al (2022) Associations of keratinocyte cancers with SNP variants in the sonic hedgehog pathway. BMC Cancer 22(1):490. https://doi.org/10.1186/S12885-022-09565-6
Villani R et al (2021) Subtype-specific analyses reveal infiltrative basal cell carcinomas are highly interactive with their environment. J Investig Dermatol 141(10):2380–2390. https://doi.org/10.1016/J.JID.2021.02.760
Hui Y et al (2021) Primary cutaneous SMARCB1-deficient carcinoma. J Cutan Pathol 48(8):1051–1060. https://doi.org/10.1111/CUP.13996
Ghlichloo I et al (2022) Synchronous basal cell carcinoma and squamous cell carcinoma of nasal vestibule with novel unique variants identified by whole-exome sequencing. In Vivo 36(1):251–257. https://doi.org/10.21873/INVIVO.12698
Sławińska M, Zabłotna M, Nowicki RJ, Sobjanek M (2021) FOXP3 and CTLA-4 genetic variants’ influence on the susceptibility and clinical course of basal cell carcinoma. Postep Dermatol Alergol 38(3):455–460. https://doi.org/10.5114/ADA.2020.93368
Wollina U, Koch A, Schönlebe J, Tchernev G (2022) Carcinosarcoma of skin (Sarcomatoid carcinoma)—a rare non-melanoma skin cancer (case review). Georgian Med. News, no. 263, pp. 7–10, Feb. 2017. https://pubmed-ncbi-nlm-nih-gov.proxy-hs.researchport.umd.edu/28452720/. Accessed 29 Jan 29
Jayarajan R (2018) A combination flap for nasal defect reconstruction. Ann Plast Surg 81(4):433–437. https://doi.org/10.1097/SAP.0000000000001483
Ogino A, Onishi K, Okada E, Nakamichi M (2018) Unit advancement flap for lower lip reconstruction. J Craniofac Surg 29(3):668–670. https://doi.org/10.1097/SCS.0000000000004217
Norris II, Cook J (2020) The cheek interpolation flap for reconstruction of auricular Mohs defects. Dermatol Surg 46(8):1039–1044. https://doi.org/10.1097/DSS.0000000000002226
Brenner MJ, Moyer JS (2017) Skin and composite grafting techniques in facial reconstruction for skin cancer. Facial Plast Surg Clin N Am 25(3):347–363. https://doi.org/10.1016/J.FSC.2017.03.007
Blume-Peytavi U et al (2016) Age-associated skin conditions and diseases: current perspectives and future options. Gerontologist 56(Suppl 2):S230–S242. https://doi.org/10.1093/GERONT/GNW003
Delpachitra MR, Heal C, Banks J, Divakaran P, Pawar M (2019) Risk factors for surgical site infection in minor dermatological surgery: a systematic review. Adv Skin Wound Care 32(5):217–226. https://doi.org/10.1097/01.ASW.0000546118.25057.1A
Etzkorn JR, Alam M (2020) What is Mohs surgery? JAMA Dermatol 156(6):716. https://doi.org/10.1001/JAMADERMATOL.2020.0039
Fania L et al (2020) Basal cell carcinoma: from pathophysiology to novel therapeutic approaches. Biomedicines 8(11):1–38. https://doi.org/10.3390/BIOMEDICINES8110449
Zito PM, Nassereddin A, Scharf R (2021) “Vismodegib,” StatPearls. [Online]. https://www.ncbi.nlm.nih.gov/books/NBK513360/. Accessed 07 Feb 2022
Funding
There is no funding to report for this publication.
Author information
Authors and Affiliations
Contributions
LB and AK wrote the main manuscript text. All authors reviewed the manuscript. Both authors contributed equally to this manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Born, L.J., Khachemoune, A. Basal cell carcinosarcoma: a systematic review and reappraisal of its challenges and the role of Mohs surgery. Arch Dermatol Res 315, 2195–2205 (2023). https://doi.org/10.1007/s00403-023-02551-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02551-3